Serum Procalcitonin Level May Predict Acute Kidney Injury in ICU Patients With Sepsis

Benha University

Status: Completed

Conditions: Acute Kidney Injury

Treatments: Diagnostic Test: measure Serum procalcitonin level

Study type: Observational

Funder types: Other

Identifiers

NCT03097393

Benha317

Details and patient eligibility

About

The aim of this study is to examine if procalcitonin (PCT) can be used for early prediction of AKI septic patients in ICU.

Full description

67 patients with sepsis were enrolled in this study. On admission, PCT was measured together with serum creatinine, urea, and other inflammatory markers. Quick Sepsis-related Organ Failure Assessment was calculated at the emergency department. Patients were classified into those with Acute kidney injury (AKI) and non-AKI groups.

Enrollment: 67 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ICU patients with sepsis

Exclusion criteria

• Patient known to have End-stage kidney disease
• Patients on Renal replacement therapy
• patients without procalcitonin level within 24 hours from admission.

Trial design

67 participants in 2 patient groups

AKI GROUP

Description:

measure Procalcitonin among Patient developed Acute kidney injury during ICU stay

Treatment:

Diagnostic Test: measure Serum procalcitonin level

Non-AKI group

Description:

measure Procalcitonin among Patient did not develop Acute kidney injury during ICU stay

Treatment:

Diagnostic Test: measure Serum procalcitonin level